• Je něco špatně v tomto záznamu ?

Chemo-enzymatic synthesis of silybin and 2,3-dehydrosilybin dimers

E. Vavříková, J. Vacek, K. Valentová, P. Marhol, J. Ulrichová, M. Kuzma, V. Křen,

. 2014 ; 19 (4) : 4115-34.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008127

Divalent or multivalent molecules often show enhanced biological activity relative to the simple monomeric units. Here we present enzymatically and chemically prepared dimers of the flavonolignans silybin and 2,3-dehydrosilybin. Their electrochemical behavior was studied by in situ and ex situ square wave voltammetry. The oxidation of monomers and dimers was similar, but adsorption onto the electrode and cell surfaces was different. A 1,1-diphenyl-2-picrylhydrazyl (DPPH) and an inhibition of microsomal lipoperoxidation assay were performed with same trend of results for silybin and 2,3-dehydrosilybin dimers. Silybin dimer showed better activity than the monomer, while on the contrary 2,3-dehydrosilybin dimer presented weaker antioxidant/antilipoperoxidant activity than its monomer. Cytotoxicity was evaluated on human umbilical vein endothelial cells, normal human adult keratinocytes, mouse fibroblasts (BALB/c 3T3) and human liver hepatocellular carcinoma cell line (HepG2). Silybin dimer was more cytotoxic than the parent compound and in the case of 2,3-dehydrosilybin its dimer showed weaker cytotoxicity than the monomer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008127
003      
CZ-PrNML
005      
20150306133050.0
007      
ta
008      
150306s2014 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules19044115 $2 doi
035    __
$a (PubMed)24699152
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vavříková, Eva $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic. vavrikova@biomed.cas.cz.
245    10
$a Chemo-enzymatic synthesis of silybin and 2,3-dehydrosilybin dimers / $c E. Vavříková, J. Vacek, K. Valentová, P. Marhol, J. Ulrichová, M. Kuzma, V. Křen,
520    9_
$a Divalent or multivalent molecules often show enhanced biological activity relative to the simple monomeric units. Here we present enzymatically and chemically prepared dimers of the flavonolignans silybin and 2,3-dehydrosilybin. Their electrochemical behavior was studied by in situ and ex situ square wave voltammetry. The oxidation of monomers and dimers was similar, but adsorption onto the electrode and cell surfaces was different. A 1,1-diphenyl-2-picrylhydrazyl (DPPH) and an inhibition of microsomal lipoperoxidation assay were performed with same trend of results for silybin and 2,3-dehydrosilybin dimers. Silybin dimer showed better activity than the monomer, while on the contrary 2,3-dehydrosilybin dimer presented weaker antioxidant/antilipoperoxidant activity than its monomer. Cytotoxicity was evaluated on human umbilical vein endothelial cells, normal human adult keratinocytes, mouse fibroblasts (BALB/c 3T3) and human liver hepatocellular carcinoma cell line (HepG2). Silybin dimer was more cytotoxic than the parent compound and in the case of 2,3-dehydrosilybin its dimer showed weaker cytotoxicity than the monomer.
650    _2
$a zvířata $7 D000818
650    _2
$a biokatalýza $7 D055162
650    _2
$a bifenylové sloučeniny $x antagonisté a inhibitory $7 D001713
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a dimerizace $7 D019281
650    _2
$a fibroblasty $x cytologie $x účinky léků $7 D005347
650    _2
$a scavengery volných radikálů $x chemická syntéza $x farmakologie $7 D016166
650    _2
$a fungální proteiny $x chemie $7 D005656
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
650    _2
$a lidé $7 D006801
650    _2
$a keratinocyty $x cytologie $x účinky léků $7 D015603
650    _2
$a lipasa $x chemie $7 D008049
650    _2
$a peroxidace lipidů $x účinky léků $7 D015227
650    _2
$a myši $7 D051379
650    _2
$a jaterní mikrozomy $x účinky léků $7 D008862
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a pikráty $x antagonisté a inhibitory $7 D010851
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a silymarin $x chemická syntéza $x farmakologie $7 D012838
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vacek, Jan $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, CZ-775 15 Olomouc, Czech Republic. jan.vacek@upol.cz.
700    1_
$a Valentová, Kateřina $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic. kata.valentova@email.cz.
700    1_
$a Marhol, Petr $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic. rtepm@seznam.cz.
700    1_
$a Ulrichová, Jitka $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, CZ-775 15 Olomouc, Czech Republic. jitka.ulrichova@upol.cz.
700    1_
$a Kuzma, Marek $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic. kuzma@biomed.cas.cz.
700    1_
$a Křen, Vladimír $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic. kren@biomed.cas.cz.
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 19, č. 4 (2014), s. 4115-34
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24699152 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150306133321 $b ABA008
999    __
$a ok $b bmc $g 1065400 $s 890927
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 19 $c 4 $d 4115-34 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Možnosti archivace